Condition: Cervical Cancer Screening · Sponsor: Milton S. Hershey Medical Center
This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.
This description comes directly from the study's public registry record.
Christina Scartozzi, DO · 610-208-4610 · cscartozzi@pennstatehealth.psu.edu
Leonard Kishel · 717-531-0003 · lkishel@pennstatehealth.psu.edu
Always discuss trial participation with your own doctor first.
| Penn State Health St. Joseph's | Reading, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05092022